Asthma and Respiratory Disorders News

Elevated baseline levels of type 2 biomarkers predicted improved lung function and reduced exacerbation rates with dupilumab among patients with asthma, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.

The Asthma Impairment and Risk Questionnaire predicted exacerbation risks for the next year and can help inform shared decision-making, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

A group of biomarkers proposed in previous research insufficiently diagnosed eosinophilic phenotypes among patients with asthma, according to a study published in Clinical and Translational Allergy.

Evidence-based care informed by digital data collection led to a lower treatment burden among patients with severe, uncontrolled asthma, researchers reported at the European Respiratory Society International Congress.

Obesity, fractional exhaled nitric oxide and maximum bronchodilator reversibility were among the factors that precited lower FEV1 over time among children with asthma, according to a study in The Journal of Allergy and Clinical Immunology.

Social, economic and environmental factors at individual and neighborhood levels mediated racial disparities in pediatric visits to the ED related to asthma, according to a study published in The Journal of Allergy and Clinical Immunology.

U.S. health care spending on respiratory conditions, especially chronic conditions like asthma and COPD, increased dramatically from 1996 to 2016, researchers reported in the American Journal of Respiratory and Critical Care Medicine.

Single maintenance and reliever therapy, also known as SMART or single-inhaler therapy, significantly reduces asthma exacerbation frequency and severity, according to a review published in Annals of Allergy, Asthma & Immunology.

The use of biologics to treat atopic disease before and during pregnancy does not seem to negatively affect maternal or fetal outcomes, according to a review published in The Journal of Allergy and Clinical Immunology: In Practice.

Members of racial and ethnic communities that have been oppressed structurally may face increased burdens of allergic and atopic disease, according to a review published in The Journal of Allergy and Clinical Immunology: In Practice.